Predictors of a Minimal Clinically Important Difference Following Omalizumab Treatment in Adult Patients With Severe Allergic Asthma

Several factors have been found to be predictors of a good response following omalizumab treatment in patients with severe allergic asthma (SAA). However, it remains unclear whether clinical characteristics can predict a minimal clinically important difference (MCID) following omalizumab treatment i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei-Chang, Fu, Pin-Kuei, Chan, Ming-Cheng, Chin, Chun-Shih, Huang, Wen-Nan, Lai, Kuo-Lung, Wang, Jiun-Long, Hung, Wei-Ting, Wu, Yi-Da, Hsieh, Chia-Wei, Wu, Ming-Feng, Chen, Yi-Hsing, Hsu, Jeng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761618/
https://www.ncbi.nlm.nih.gov/pubmed/35047521
http://dx.doi.org/10.3389/fmed.2021.762318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761618/
https://www.ncbi.nlm.nih.gov/pubmed/35047521
http://dx.doi.org/10.3389/fmed.2021.762318

Ejemplares similares